Expert Q&A: Trends in Precision Medicine
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Subscribe today for access to
Articles and Reports
Latest Articles
The Diagnostics Pipeline: FDA Issues Groundbreaking Clearance for an RSV Vaccine
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
New Blood-Based PTSD Biomarkers Revealed
A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.
Prostate Cancer: National Guidelines Have Not Stopped Overuse of Low-Value PSA Screening in Older Males
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
CDC Calls Continued Rise in Cases of STIs “Alarming”
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
How Could Cheaper Genomic Sequencing Affect the Clinical Testing Industry?
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
AACC Offers New Guidance for HPV and Cervical Cancer Screening
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.
New Device Predicts the Efficacy of Hypnosis Treatment for Pain
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
How Technology Is Solving Key Challenges in the Clinical Lab
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
Simplifying Antidepressant Quantification in Clinical Labs
A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.
